Insufficient scRNA-seq data for expression of SPINK9 at single-cell level.
Insufficient scRNA-seq data for expression of SPINK9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 83% | 4.92 | 213 / 258 | 4% | 0.08 | 10 / 230 |
| brain | 82% | 6.65 | 2162 / 2642 | 1% | 0.01 | 4 / 705 |
| thymus | 74% | 2.65 | 486 / 653 | 5% | 0.07 | 32 / 605 |
| pancreas | 76% | 3.18 | 249 / 328 | 3% | 0.07 | 5 / 178 |
| heart | 77% | 4.19 | 666 / 861 | 0% | 0 | 0 / 0 |
| prostate | 69% | 3.13 | 170 / 245 | 2% | 0.02 | 8 / 502 |
| ovary | 66% | 2.16 | 118 / 180 | 0% | 0.00 | 1 / 430 |
| uterus | 61% | 1.44 | 103 / 170 | 2% | 0.04 | 9 / 459 |
| intestine | 54% | 1.34 | 522 / 966 | 1% | 0.01 | 3 / 527 |
| bladder | 52% | 1.33 | 11 / 21 | 2% | 0.08 | 11 / 504 |
| lung | 48% | 1.16 | 280 / 578 | 4% | 0.15 | 43 / 1155 |
| breast | 50% | 1.31 | 228 / 459 | 1% | 0.03 | 10 / 1118 |
| skin | 49% | 1.43 | 886 / 1809 | 1% | 0.03 | 5 / 472 |
| stomach | 47% | 1.08 | 169 / 359 | 1% | 0.03 | 4 / 286 |
| liver | 48% | 1.10 | 108 / 226 | 0% | 0 | 0 / 406 |
| esophagus | 47% | 1.07 | 681 / 1445 | 1% | 0.01 | 1 / 183 |
| kidney | 45% | 1.38 | 40 / 89 | 1% | 0.07 | 10 / 901 |
| spleen | 42% | 0.80 | 102 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 41% | 0.76 | 553 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 37% | 0.76 | 443 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 28% | 0.53 | 226 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 18% | 0.30 | 164 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SPINK9 |
| Protein name | Serine peptidase inhibitor Kazal type 9 Serine protease inhibitor Kazal-type 9 (Lymphoepithelial Kazal-type-related inhibitor 2) |
| Synonyms | LEKTI2 |
| Description | FUNCTION: Serine protease inhibitor which specifically inhibits KLK5. May contribute to the regulation of the desquamation process in skin by inhibiting KLK5. . |
| Accessions | Q5DT21 ENST00000377906.2 D6RJC5 ENST00000511717.6 |